Evidence map›Paper›PMID 33800026›Full record

ArticleTropical medicine and infectious disease2021

Antimicrobial Resistance in a Tertiary Care Hospital in Armenia: 2016-2019.

Hayk Davtyan, Ruzanna Grigoryan, Lyudmila Niazyan, Mher Davidyants, Tehmine Ghalechyan, Karapet Davtyan

Open access · goldAbstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Molecular Epidemiology and In-Depth Characterization ofInternational journal of molecular sciences · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hayk DavtyanTuberculosis Research and Prevention Center NGO, Yerevan 0014, Armenia.ORCID 0000-0002-9836-4261
Ruzanna GrigoryanTuberculosis Research and Prevention Center NGO, Yerevan 0014, Armenia.
Lyudmila NiazyanNork Infection Clinical Hospital of Ministry of Health of Armenia, Yerevan 0047, Armenia.
Mher DavidyantsNork Infection Clinical Hospital of Ministry of Health of Armenia, Yerevan 0047, Armenia.
Tehmine GhalechyanNork Infection Clinical Hospital of Ministry of Health of Armenia, Yerevan 0047, Armenia.
Karapet DavtyanTuberculosis Research and Prevention Center NGO, Yerevan 0014, Armenia.ORCID 0000-0003-1583-2590

Funding

TDR N/A; Joint TDR/EURO Small Grants Scheme for implementation research in infectious diseases
6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is the acquired ability of pathogens to withstand antimicrobial treatment. To bridge the gap in knowledge for implementing effective and targeted interventions in relation to the AMR in Armenia, we designed this study to explore the performance of AMR diagnostics and the profile of AMR in the Nork Infection Clinical Hospital (NICH) for the period of 2016-2019, particularly to (i) determine the proportions of antimicrobial resistance among all samples tested at the hospital laboratory, (ii) determine the proportion of resistance against specific antimicrobials, and (iii) identify factors associated with AMR. A cross-sectional study was conducted with a secondary data analysis that included all the patients tested for AMR in the laboratory of the NICH for the period of 2016-2019. For this period, only 107 (0.3%) patients out of 36,528 had their AMR test results available and of them, 87 (81%) had resistance at least to one tested antimicrobial. This study has provided some valuable information on the AMR situation in Armenia. The results call for immediate actions to control the access to and the use of antimicrobials, strengthen AMR surveillance, and improve laboratory capacity for the proper and fast identification of drug resistance through a comprehensive system.

Indexed as

antimicrobial resistancedrug resistanceInternational Health Regulationsoperational researchrisk factorsstewardshipsurveillance

Identifiers

PMID33800026
PMCPMC8005984
OpenAlexW3134114785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.